Roivant Sciences Ltd (ROIV NASDAQ) stock market data APIs
$15.1539
0.64(4.2%)
as of September 17, 2025
Try our APIs with
free plan!
Roivant Sciences Ltd Financial Data Overview
Price chart is built with
Anychart
Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody that targets the neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising lipid nanoparticle (LNP) platform and ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.
Prev. Close
15.1539
Open
15.7894
High
16.164
Low
15.2039
52 wk Range
8.73-16.05
Market Cap
10 434 M
Shares Outstanding
683 M
Revenue
23 233 K
EPS
-0.2501
Beta
1.151
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roivant Sciences Ltd (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roivant Sciences Ltd data using free add-ons & libraries
Get Roivant Sciences Ltd Fundamental Data
Roivant Sciences Ltd Fundamental data includes:
- Net Revenue: 23 233 K
- EBITDA: -1 148 260 992
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: -0.2462
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roivant Sciences Ltd News
New
Stocks Settle Mixed on Hawkish Fed Chair Powell Comments
The S&P 500 Index ($SPX) (SPY) on Wednesday closed down -0.10%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.57%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.21%. Septemb...
Stocks Settle Mixed on Hawkish Fed Chair Powell Comments
The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Wednesday closed down -0.10%, the Dow Jones Indust...
The Federal Reserve Cuts Interest Rate by a Quarter-Percentage-Point, Signals 2 More Before the End of the Year
The S&P 500 Index ($SPX) (SPY) today is up -0.17%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.77%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.80%. In a move that was largely an...
Stocks Tread Water as FOMC Decision Nears
The S&P 500 Index ($SPX) (SPY) today is down -0.10%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.62%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.42%. September E-mini S&P futur...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
